Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
2.
Comput Biol Med ; 138: 104891, 2021 11.
Article in English | MEDLINE | ID: covidwho-1439957

ABSTRACT

The coronavirus disease 2019 (COVID-19) is caused by the infection of highly contagious severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), also known as the novel coronavirus. In most countries, the containment of this virus spread is not controlled, which is driving the pandemic towards a more difficult phase. In this study, we investigated the impact of the Bacille Calmette Guerin (BCG) vaccination on the severity and mortality of COVID-19 by performing transcriptomic analyses of SARS-CoV-2 infected and BCG vaccinated samples in peripheral blood mononuclear cells (PBMC). A set of common differentially expressed genes (DEGs) were identified and seeded into their functional enrichment analyses via Gene Ontology (GO)-based functional terms and pre-annotated molecular pathways databases, and their Protein-Protein Interaction (PPI) network analysis. We further analysed the regulatory elements, possible comorbidities and putative drug candidates for COVID-19 patients who have not been BCG-vaccinated. Differential expression analyses of both BCG-vaccinated and COVID-19 infected samples identified 62 shared DEGs indicating their discordant expression pattern in their respected conditions compared to control. Next, PPI analysis of those DEGs revealed 10 hub genes, namely ITGB2, CXCL8, CXCL1, CCR2, IFNG, CCL4, PTGS2, ADORA3, TLR5 and CD33. Functional enrichment analyses found significantly enriched pathways/GO terms including cytokine activities, lysosome, IL-17 signalling pathway, TNF-signalling pathways. Moreover, a set of identified TFs, miRNAs and potential drug molecules were further investigated to assess their biological involvements in COVID-19 and their therapeutic possibilities. Findings showed significant genetic interactions between BCG vaccination and SARS-CoV-2 infection, suggesting an interesting prospect of the BCG vaccine in relation to the COVID-19 pandemic. We hope it may potentially trigger further research on this critical phenomenon to combat COVID-19 spread.


Subject(s)
BCG Vaccine , COVID-19 , Humans , Leukocytes, Mononuclear , Pandemics , SARS-CoV-2 , Vaccination
3.
J Public Aff ; 21(4): e2624, 2021 Nov.
Article in English | MEDLINE | ID: covidwho-1051324

ABSTRACT

During COVID-19 lockdown, individuals were asked to leave their home only to meet the most urgent needs, such as grocery purchases and medical emergencies. This study aimed to know the consumers' health safety practices and their concerns toward grocery shopping and to know their adoption of healthier food as a result of the outbreak. An online survey was conducted during the second month of the COVID-19 lockdown. This study includes 212 respondents. Appropriate statistical tools were used to analyze the data. The findings of the study revealed that females were ahead compared to males in pursuing health safety practices during grocery shopping, but the frequency of following physical distancing for both males and females was not up to the mark. The most important concern about grocery shopping was fear of unavailability of stocks and fear of getting infected from grocery storekeepers. It was also found that, compared to earlier, people had reduced their frequency of grocery shopping and tried to shop quickly and efficiently. People bought more packaged foods and also made purchases from brands that were new to them. As a result of the COVID-19 pandemic, the adoption of healthier food habits varied significantly with gender, age, and household income of the respondents. This study indicates that there is a need to raise awareness among people on how to shop safely in grocery stores and that good hygiene practice should be followed in grocery stores to mitigate the risk of infection to consumers.

4.
Med Hypotheses ; 142: 109754, 2020 Sep.
Article in English | MEDLINE | ID: covidwho-102391

ABSTRACT

The recent global pandemic created by the Coronavirus SARS-CoV-2, started in Wuhan, China in December 2019, has generated panic, both in term of human death (4-5% of infected patients identified through testing) and the global economy. Human sufferings seem to be continuing, and it is not clear how long this will continue and how much more destruction it is going to cause until complete control is achieved. One of the most disturbing issues is Covid-19 treatment; although a large number of medications, previously used successfully with other viruses (including Chinese herbal medicines and anti-malaria drugs), are under consideration, there remain questions as to whether they can play a satisfactory role for this disease. Global attempts are ongoing to find the drugs for the treatment of this virus but none of the antiviral drugs used for treatment of other human viral infection is working and hence attempts to find new drugs are continuing. Here the author is proposing that 5-Fluorouracil (5-FU) which when used on its own is failing as an antiviral agent due to the removal of this compound by proof reading ability exceptionally found in Coronaviruses. The author here is proposing to test 5-FU in combination with a number of deoxynucleosides on animal models infected with this Covid-19. Should encouraging results ensue, therapies could then be tried on patients.


Subject(s)
Coronavirus Infections/drug therapy , Deoxyribonucleosides/administration & dosage , Deoxyribose/administration & dosage , Fluorouracil/administration & dosage , Pneumonia, Viral/drug therapy , Adenosine Monophosphate/administration & dosage , Adenosine Monophosphate/analogs & derivatives , Alanine/administration & dosage , Alanine/analogs & derivatives , Betacoronavirus , COVID-19 , Chloroquine/administration & dosage , Chloroquine/analogs & derivatives , Clinical Trials as Topic , Drug Administration Schedule , Drug Synergism , Humans , Inflammation/drug therapy , Models, Theoretical , Pandemics , SARS-CoV-2 , COVID-19 Drug Treatment
SELECTION OF CITATIONS
SEARCH DETAIL